Merkel cell carcinoma of the lower leg with retroperitoneal GIST: a very rare association

[1]  S. Imafuku,et al.  Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases , 2015, International Journal of Clinical Oncology.

[2]  L. Giovanella,et al.  Prognostic Significance of Sentinel Lymph Node Mapping in Merkel Cell Carcinoma: Systematic Review and Meta-Analysis of Prognostic Studies , 2014, BioMed research international.

[3]  N. Iqbal,et al.  Imatinib: A Breakthrough of Targeted Therapy in Cancer , 2014, Chemotherapy research and practice.

[4]  L. Cornelius,et al.  Chronic mTOR activation promotes cell survival in Merkel cell carcinoma. , 2014, Cancer letters.

[5]  S. George,et al.  Recent advances in the treatment of gastrointestinal stromal tumors , 2014, Therapeutic advances in medical oncology.

[6]  G. Wilson,et al.  Gene Expression Differences Predict Treatment Outcome of Merkel Cell Carcinoma Patients , 2014, Journal of skin cancer.

[7]  J. Becker,et al.  Clinical remission of Merkel cell carcinoma after treatment with imatinib. , 2013, Journal of the American Academy of Dermatology.

[8]  U. Wollina,et al.  Merkelzellkarzinom: eine Überprüfung und Aktualisierung über die Pathogenese, Diagnose und Therapieansätze , 2013, Wiener Medizinische Wochenschrift.

[9]  J. Cardoso,et al.  Merkel cell carcinoma: a review and update on aetiopathogenesis, diagnosis and treatment approaches. , 2013, Wiener medizinische Wochenschrift.

[10]  V. Gebski,et al.  Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. , 2012, Journal of the American Academy of Dermatology.

[11]  B. Dréno,et al.  Treatment of a multicentric Merkel cell carcinoma using imatinib. , 2011, European journal of dermatology : EJD.

[12]  F. Cirillo.  Neuroendocrine tumors and their association with rare tumors: observation of 4 cases. , 2010, European review for medical and pharmacological sciences.

[13]  A. Hansen,et al.  Merkel cell carcinoma: incidence, mortality, and risk of other cancers. , 2010, Journal of the National Cancer Institute.

[14]  I. Espinosa,et al.  The Utility of Discovered on Gastrointestinal Stromal Tumor 1 (DOG1) Antibody in Surgical Pathology—the GIST of It , 2010, Advances in anatomic pathology.

[15]  N. Kiviat,et al.  Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. , 2009, The Journal of investigative dermatology.

[16]  J. Crowley,et al.  Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  U. Wollina,et al.  Merkel cell carcinoma – a retrospective analysis of 17 cases , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  C. Toker.  Trabecular carcinoma of the skin. , 1972, Archives of dermatology.

[19]  Z. Cope.  Institute of Pathology , 1964 .